Clinical Trial Update: Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting safety and efficacy of Mix Vaccine in pancreatic carcinoma, completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neoplasms

Drugs mentioned

• Mix Vaccine

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Pancreatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED